| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Serine/threonine-protein kinase pim-1 |
|---|
| Ligand | BDBM50510184 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_1840683 (CHEMBL4340982) |
|---|
| EC50 | 865±n/a nM |
|---|
| Citation |  Martínez-González, S; Rodríguez-Arístegui, S; Gómez de la Oliva, CA; Hernández, AI; González Cantalapiedra, E; Varela, C; García, AB; Rabal, O; Oyarzabal, J; Bischoff, JR; Klett, J; Albarrán, MI; Cebriá, A; Ajenjo, N; García-Serelde, B; Gómez-Casero, E; Cuadrado-Urbano, M; Cebrián, D; Blanco-Aparicio, C; Pastor, J Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors. Eur J Med Chem168:87-109 (2019) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Serine/threonine-protein kinase pim-1 |
|---|
| Name: | Serine/threonine-protein kinase pim-1 |
|---|
| Synonyms: | PIM-1 Kinase | PIM1 | PIM1_HUMAN | Proto-oncogene serine/threonine-protein kinase Pim-1 | Serine/threonine-protein kinase (PIM1) | Serine/threonine-protein kinase PIM | Serine/threonine-protein kinase PIM1 | Serine/threonine-protein kinase pim-1 (PIM1) |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 35681.82 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P11309 |
|---|
| Residue: | 313 |
|---|
| Sequence: | MLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSD
NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL
ERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG
ELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI
PFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETA
EIHLHSLSPGPSK
|
|
|
|---|
| BDBM50510184 |
|---|
| n/a |
|---|
| Name | BDBM50510184 |
|---|
| Synonyms: | CHEMBL4440880 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C24H27N7O |
|---|
| Mol. Mass. | 429.5175 |
|---|
| SMILES | CN1CCOc2c1cnn1c(nnc21)-c1ccc2cccc(NCC3CCNCC3)c2c1 |
|---|
| Structure | 
|
|---|
Search and Browse
